Skip to main navigation
Caribou Biosciences, Inc. Logo

SEC filing details

Document Details

Form
10-K
Filing Date
Mar 21, 2022
Document Date
Dec 31, 2021
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Caribou Biosciences, Inc.
Issuer
Caribou Biosciences, Inc.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT

Print page

Email alerts

RSS feeds

Investor contact

  • News & events
    • Press releases
    • Events
    • Presentations
  • Stock information
    • Stock quote & chart
    • Analyst coverage
  • Corporate governance
    • Documents & charters
    • Leadership
    • Board of Directors
    • Committee composition
    • Board diversity matrix
  • Financials & filings
    • SEC filings
    • Annual reports
    • Quarterly results
  • IR resources
    • FAQs
    • Email alerts
    • Contact IR
  • More
    • About
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Partnering
    • Technology
      • chRDNA technology
      • CAR-T cell therapy platform
      • CAR-NK cell therapy platform
      • Scientific publications
    • Pipeline
      • T cell pipeline
      • NK cell pipeline
      • Clinical trials
    • Careers
      • Job opportunities
      • Values
      • DE&I
      • Benefits
    • Investors
      • News & events
        • Press releases
        • Events
        • Presentations
      • Stock information
        • Stock quote & chart
        • Analyst coverage
      • Corporate governance
        • Documents & charters
        • Leadership
        • Board of Directors
        • Committee composition
        • Board diversity matrix
      • Financials & filings
        • SEC filings
        • Annual reports
        • Quarterly results
      • IR resources
        • FAQs
        • Email alerts
        • Contact IR
    • Contact
    • About
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Partnering
    • Technology
      • chRDNA technology
      • CAR-T cell therapy platform
      • CAR-NK cell therapy platform
      • Scientific publications
    • Pipeline
      • T cell pipeline
      • NK cell pipeline
      • Clinical trials
    • Careers
      • Job opportunities
      • Values
      • DE&I
      • Benefits
    • Investors
      • News & events
        • Press releases
        • Events
        • Presentations
      • Stock information
        • Stock quote & chart
        • Analyst coverage
      • Corporate governance
        • Documents & charters
        • Leadership
        • Board of Directors
        • Committee composition
        • Board diversity matrix
      • Financials & filings
        • SEC filings
        • Annual reports
        • Quarterly results
      • IR resources
        • FAQs
        • Email alerts
        • Contact IR
    • Contact

    Caribou Biosciences, Inc. Logo

    Caribou Biosciences, Inc.
    2929 7th Street, Suite 105
    Berkeley, CA 94710
    Tel: 510-982-6030

    © 2024 Caribou Biosciences, Inc. All rights reserved.
    • Privacy policy
    • Terms of use
    • Twitter
    • linkedin
    Website Design: Hane Chow, Inc .